CanDiag's Unattributed Round

CanDiag raised a round of funding on September 11, 2013.

CanDiag has a worldwide exclusive license to a tumor antibody that has been used to develop a blood test for the early detection of breast cancer. The company aims to expand its capabilities and offe…

Articles about CanDiag's Unattributed Round: